Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
about
Substance use and the treatment of resistant depression in adolescents.Practitioner review: adolescent alcohol use disorders: assessment and treatment issues.Alcohol and depression.Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.LONGER-TERM EFFECTIVENESS OF CBT IN TREATMENT OF COMORBID AUD/MDD ADOLESCENTS.Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescentsPharmacotherapy of comorbid mood, anxiety, and substance use disorders.Neurobiological processes in adolescent addictive disorders.The Association between Alcohol Dependence and Depression before and after Treatment for Alcohol Dependence.The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trialDouble-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorderTreatment of comorbid adolescent cannabis use and major depressive disorder.Comorbid adolescent substance use and major depressive disorders: a review.Time to abandon the self-medication hypothesis in patients with psychiatric disorders.Exercise training - A beneficial intervention in the treatment of alcohol use disorders?Depression and Alcohol Use in a National Sample of Hispanic Adolescents.Pharmacotherapy for adolescent alcohol use disorder.
P2860
Q33956890-F361B05F-D016-465C-BA2B-1AC8E7A7A581Q33960510-BECA550D-1CED-4976-A14F-B64810888164Q34025976-9567A300-C247-4978-9C97-A08F6049C101Q34158675-BD7AB447-4F3D-4987-B9E0-96436D1C4620Q34277168-0FD09831-8C55-45DA-8B6D-2D94C234D804Q34357284-C5958702-56E1-440B-907E-52635F81832FQ34372579-3CE54E91-EB76-4281-B2E2-FB385612303EQ34981271-892806FF-36A3-4E09-B7FA-9FCC78DBBFBDQ36311034-97E44194-92EA-4650-AA3C-C00CD270AE44Q36508688-A5BBF25C-5F35-4057-B45E-693B47753C73Q36857632-8DC57C23-B6D7-4100-B472-2FF9116E41ECQ37152939-2FD6AA63-F406-4B48-858F-74766E24327BQ37288084-29D66529-8EF9-44E7-9B09-A5EC16A017E4Q37591185-D036F4D4-67D6-47B6-8DC2-0D2C79E9BF05Q37740963-438ED39E-1E85-4E06-9B9E-398EEE2B2A5AQ38038232-C1E57D0E-50CE-42A3-928E-FDF9276A6708Q38664894-DCA5F3AB-B8E6-4B09-80BC-8EC560F8C161Q46515982-48BAC507-A867-4400-BF15-DADEDFEDA6C4Q47984054-9E377689-B5D5-499B-824D-45E5B70812D3
P2860
Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Fluoxetine in adolescents with ...... disorder: an open-label trial.
@en
Fluoxetine in adolescents with ...... disorder: an open-label trial.
@nl
type
label
Fluoxetine in adolescents with ...... disorder: an open-label trial.
@en
Fluoxetine in adolescents with ...... disorder: an open-label trial.
@nl
prefLabel
Fluoxetine in adolescents with ...... disorder: an open-label trial.
@en
Fluoxetine in adolescents with ...... disorder: an open-label trial.
@nl
P2093
P1433
P1476
Fluoxetine in adolescents with ...... disorder: an open-label trial.
@en
P2093
Birmaher B
Bukstein OG
Cornelius JR
Pollock NK
Salloum IM
P304
P356
10.1016/S0306-4603(00)00152-0
P577
2001-09-01T00:00:00Z